Journal Article Summary

The article investigates the potential of memantine, a drug typically used to treat Alzheimer's disease, as a treatment for Chagas disease, which is caused by the parasite Trypanosoma cruzi. Chagas disease affects millions of people, particularly in the Americas, and current treatments are limited and often have severe side effects, especially in the chronic phase of the disease. This study aims to explore whether memantine can effectively reduce the infection and associated complications caused by T. cruzi.

The researchers conducted experiments both in vitro (in the lab) and in vivo (in mice) to assess memantine's effects on T. cruzi infections. They found that memantine reduced the number of infected macrophages and decreased the levels of nitric oxide and calcium in these cells, suggesting a potential mechanism for its action. In mice treated with memantine, there was a significant reduction in parasitemia (the presence of parasites in the blood), cardiac parasitic load, and inflammatory responses, leading to improved survival rates compared to untreated mice.

However, the study has limitations, including the need for further research to confirm memantine's effectiveness and safety in humans. Patients and caregivers should consult healthcare professionals before considering any new treatment options, especially since Chagas disease can have serious long-term health effects. Discussing the findings of this study with a healthcare provider may help in understanding potential new avenues for treatment and managing the disease more effectively.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Santos Souza Higo Fernando, Rocha Sandra Carla, Damasceno Flávia Silva, Rapado Ludmila Nakamura, Pral Elisabeth Mieko Furusho, Marinho Claudio Romero Farias, Silber Ariel Mariano. The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi. PLoS Neglected Tropical Diseases 2019. DOI: 10.1371/journal.pntd.0007226. PMID: 31536489. PMCID: PMC6752752.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]